Cholangiocarcinoma

S. DeMorrow, H. Francis, M. Marzioni, D. Leyva-Illades, Y. Han, G. Alpini

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cholangiocarcinomas (CCAs) arise after the neoplastic transformation of the cholangiocytes that Line the intra- and extrahepatic biLiary epitheLium. The symptoms usually do not present until late in the course of the disease by which time they are relatively resistant to chemotherapeutic agents and, as such, are difficult to treat and display a poor prognosis. Because of the relative rarity of this disease, the overall volume of research into the molecular pathophysiology associated with this disease is small when compared to other, more prevalent tumors. However, the incidence of this devastating cancer is on the rise and renewed efforts to understand the pathogenesis of CCA is needed to design novel therapeutic strategies to combat this disease. This article summarizes the recent advances of our knowledge and understanding of CCA and highLights potential novel therapeutic strategies that may prove useful to treat this deadly disease.

Original languageEnglish (US)
Title of host publicationPathobiology of Human Disease
Subtitle of host publicationA Dynamic Encyclopedia of Disease Mechanisms
PublisherElsevier Inc.
Pages1894-1911
Number of pages18
ISBN (Electronic)9780123864567
ISBN (Print)9780123864574
DOIs
StatePublished - Jan 1 2014

Fingerprint

Cholangiocarcinoma
Neoplasms
Epithelium
Incidence
Therapeutics
Research

Keywords

  • Autocrine/paracrine regulation
  • BiLiary tree
  • Biogenic amines
  • Cancer
  • Cholangiocarcinoma
  • Growth factors
  • Inhibition
  • Metastasis
  • Microenvironment
  • Models
  • Neoplasia
  • Neuroendocrine
  • ProLiferation
  • Treatment
  • Tumor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DeMorrow, S., Francis, H., Marzioni, M., Leyva-Illades, D., Han, Y., & Alpini, G. (2014). Cholangiocarcinoma. In Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms (pp. 1894-1911). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-386456-7.04214-3

Cholangiocarcinoma. / DeMorrow, S.; Francis, H.; Marzioni, M.; Leyva-Illades, D.; Han, Y.; Alpini, G.

Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., 2014. p. 1894-1911.

Research output: Chapter in Book/Report/Conference proceedingChapter

DeMorrow, S, Francis, H, Marzioni, M, Leyva-Illades, D, Han, Y & Alpini, G 2014, Cholangiocarcinoma. in Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., pp. 1894-1911. https://doi.org/10.1016/B978-0-12-386456-7.04214-3
DeMorrow S, Francis H, Marzioni M, Leyva-Illades D, Han Y, Alpini G. Cholangiocarcinoma. In Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc. 2014. p. 1894-1911 https://doi.org/10.1016/B978-0-12-386456-7.04214-3
DeMorrow, S. ; Francis, H. ; Marzioni, M. ; Leyva-Illades, D. ; Han, Y. ; Alpini, G. / Cholangiocarcinoma. Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., 2014. pp. 1894-1911
@inbook{38f770e01d5e4a24a9339fdeb287b33b,
title = "Cholangiocarcinoma",
abstract = "Cholangiocarcinomas (CCAs) arise after the neoplastic transformation of the cholangiocytes that Line the intra- and extrahepatic biLiary epitheLium. The symptoms usually do not present until late in the course of the disease by which time they are relatively resistant to chemotherapeutic agents and, as such, are difficult to treat and display a poor prognosis. Because of the relative rarity of this disease, the overall volume of research into the molecular pathophysiology associated with this disease is small when compared to other, more prevalent tumors. However, the incidence of this devastating cancer is on the rise and renewed efforts to understand the pathogenesis of CCA is needed to design novel therapeutic strategies to combat this disease. This article summarizes the recent advances of our knowledge and understanding of CCA and highLights potential novel therapeutic strategies that may prove useful to treat this deadly disease.",
keywords = "Autocrine/paracrine regulation, BiLiary tree, Biogenic amines, Cancer, Cholangiocarcinoma, Growth factors, Inhibition, Metastasis, Microenvironment, Models, Neoplasia, Neuroendocrine, ProLiferation, Treatment, Tumor",
author = "S. DeMorrow and H. Francis and M. Marzioni and D. Leyva-Illades and Y. Han and G. Alpini",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-386456-7.04214-3",
language = "English (US)",
isbn = "9780123864574",
pages = "1894--1911",
booktitle = "Pathobiology of Human Disease",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Cholangiocarcinoma

AU - DeMorrow, S.

AU - Francis, H.

AU - Marzioni, M.

AU - Leyva-Illades, D.

AU - Han, Y.

AU - Alpini, G.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cholangiocarcinomas (CCAs) arise after the neoplastic transformation of the cholangiocytes that Line the intra- and extrahepatic biLiary epitheLium. The symptoms usually do not present until late in the course of the disease by which time they are relatively resistant to chemotherapeutic agents and, as such, are difficult to treat and display a poor prognosis. Because of the relative rarity of this disease, the overall volume of research into the molecular pathophysiology associated with this disease is small when compared to other, more prevalent tumors. However, the incidence of this devastating cancer is on the rise and renewed efforts to understand the pathogenesis of CCA is needed to design novel therapeutic strategies to combat this disease. This article summarizes the recent advances of our knowledge and understanding of CCA and highLights potential novel therapeutic strategies that may prove useful to treat this deadly disease.

AB - Cholangiocarcinomas (CCAs) arise after the neoplastic transformation of the cholangiocytes that Line the intra- and extrahepatic biLiary epitheLium. The symptoms usually do not present until late in the course of the disease by which time they are relatively resistant to chemotherapeutic agents and, as such, are difficult to treat and display a poor prognosis. Because of the relative rarity of this disease, the overall volume of research into the molecular pathophysiology associated with this disease is small when compared to other, more prevalent tumors. However, the incidence of this devastating cancer is on the rise and renewed efforts to understand the pathogenesis of CCA is needed to design novel therapeutic strategies to combat this disease. This article summarizes the recent advances of our knowledge and understanding of CCA and highLights potential novel therapeutic strategies that may prove useful to treat this deadly disease.

KW - Autocrine/paracrine regulation

KW - BiLiary tree

KW - Biogenic amines

KW - Cancer

KW - Cholangiocarcinoma

KW - Growth factors

KW - Inhibition

KW - Metastasis

KW - Microenvironment

KW - Models

KW - Neoplasia

KW - Neuroendocrine

KW - ProLiferation

KW - Treatment

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85043253682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043253682&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-386456-7.04214-3

DO - 10.1016/B978-0-12-386456-7.04214-3

M3 - Chapter

AN - SCOPUS:85043253682

SN - 9780123864574

SP - 1894

EP - 1911

BT - Pathobiology of Human Disease

PB - Elsevier Inc.

ER -